Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis
Jennifer M. McCoy, Joan R. Wicks, Laurent P. Audoly
Jennifer M. McCoy, Joan R. Wicks, Laurent P. Audoly
View: Text | PDF
Article Genetics

The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis

  • Text
  • PDF
Abstract

Research Article

Authors

Jennifer M. McCoy, Joan R. Wicks, Laurent P. Audoly

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
Targeted genetic deletion of the EP4 receptor gene protects the animals ...
Targeted genetic deletion of the EP4 receptor gene protects the animals from arthritis-induced histological damage. Representative histological sections (a–d) from diseased EP4+/+ and EP4–/– mice demonstrate the significant reduction in damage as shown by safranin O staining (red color signifies proteoglycan presence). Wild-type mice developed severe arthritis with the formation of multiple erosions on the cartilage surface, cellular hyperplasia, and pannus formation. The articular cartilage of EP4–/– mice was significantly protected from disease. (a) EP4+/+ stifle joint (2× magnification). (b) EP4–/– stifle joint (2× magnification). (c) Stifle joint synovial space in an EP4+/+ animal (10× magnification). (d) Stifle joint synovial space in an EP4–/– animal (10× magnification). (e and f) Type II collagen neoepitope staining in the stifle synovial joint of EP4+/+ and EP4–/– animals, respectively (20× magnification). An increase in staining (EP4+/+ >> EP4–/–) correlates with an increase in type II collagen breakdown (EP4+/+ >> EP4–/–), a hallmark of arthritis.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts